Semnele diacritice între imperiozitate, îngăduinţă și repudiere
DOI: 10.24193/rielma.17.2024.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revue Internationale d’Etudes en Langues Modernes Appliquées/ International Review of Studies in Applied Modern Languages, 2024. Verfasst von Anamaria Milonean.
Abstract (Originalsprache)
The literature on diacritical marks in the virtual environment helps us understand how contemporary speakers of Romanian relate to this issue. The latter fall into two main categories: those who are committed to the use of diacritics in written texts on grounds related to coherent linguistic argumentation and those who consider them unnecessary for various reasons, such as, most frequently, convenience or some technology shortcomings; however, there are also intermediate categories of speakers who indicate that the use of diacritics is mandatory only in certain written communication contexts. After a brief description of the typology and origin of Romanian diacritical marks, this paper highlights the arguments for and against the use of diacritics in Romanian writing, then examines the data gathered in a survey on this topic proposed to the staff of the Faculty of Letters of Babeș-Bolyai University of Cluj-Napoca.
Zitieren
APA
Milonean, A. (2024). Semnele diacritice între imperiozitate, îngăduinţă și repudiere. Revue Internationale d’Etudes en Langues Modernes Appliquées/ International Review of Studies in Applied Modern Languages. https://doi.org/10.24193/rielma.17.2024.4
Vancouver
Milonean A. Semnele diacritice între imperiozitate, îngăduinţă și repudiere. Revue Internationale d’Etudes en Langues Modernes Appliquées/ International Review of Studies in Applied Modern Languages. 2024. doi:10.24193/rielma.17.2024.4
BibTeX
@article{Milonean2024,
author = {Milonean, Anamaria},
title = {Semnele diacritice între imperiozitate, îngăduinţă și repudiere},
journal = {Revue Internationale d’Etudes en Langues Modernes Appliquées/ International Review of Studies in Applied Modern Languages},
year = {2024},
doi = {10.24193/rielma.17.2024.4}
}
EUVIMED